All posts tagged
A Brand New Outlook on Induced Pluripotent Stem Cells
LAB282 Awards Second Funding Round to 5 Academic Projects at Oxford
Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy
What are the Best Countries to Recruit Biotech Talents in 2017?
Evotec launches New Biotech to tackle the Most Deadly Diseases
More News! Trump targets Pharma, €1B Deal for Ipsen, & a Hep B update
Top European VC and CRO fund Young Metabolic Disease Biotech
Can partnerships between Biotechs and Academia be the Key to Success?
Evotec closes the year partnering with Celgene to treat Alzheimer’s
Evotec gets hold of CRISPR in a new Partnership with Merck
Evotec chooses Oxford as Proving Ground for Academia-Industry Bridge
What a foretaste: Meet these three awesome Speakers for Refresh!
Labiotech UG, All Rights Reserved -
Send this to friend